- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
August 3, 2015 (Healio) - Pregnant women at high risk for developing gestational diabetes can reduce their chances of developing the disease by as much as 39% through a series of moderate lifestyle changes, according to research in Diabetes Care.
"The results of the study are highly promising and in line with previous published [type 2 diabetes] prevention studies," Saila B. Koivusalo, MD, of the departm
August 3, 2015 (Healio) - The risk for dementia among older adults was increased with newly diagnosed diabetes, according to recent study findings published in Diabetes Care.
"This is of serious concern given the aging population, increasing prevalence of diabetes, and the limited effective treatment currently available for dementia," the researchers wrote. "This increased risk was independent of pre-existing [corona
July 30, 2015 (MassDevice) - Medtronic (NYSE:MDT) is informing customers with a select number of its MiniMed 620G and 640G insulin pumps of an issue with the Bolus screen displaying a bolus amount that is not up to date, according to an FDA report filed last week.
Medtronic began notifying customers with the devices on June 19, informing them of an error with the Bolus wizard in which the screen will not time out and end up displaying the wrong bolus amount, according to the FDA filing.<
Type 1 Diabetes Patients have Lower Blood Levels of Four Proteins that Protect Against Immune Attack
July 30, 2015 (MedicalXPress) — Patients with type 1 diabetes have significantly lower blood levels of four proteins that help protect their tissue from attack by their immune system, scientists report.
Conversely, their first-degree relatives, who share some of the high-risk genes but do not have the disease, have high levels of these proteins circulating in their blood, said Dr. Jin-Xiong She, director of the Center for Biotechnology and Genomic Medicine at the Medica
July 30, 2015 (Endocrinology Advisor) — For canagliflozin-treated patients with type 2 diabetes, the incidence of serious adverse events of diabetic ketoacidosis (DKA) is low, according to research published in Diabetes Care.
Ngozi Erondu, MPH, from Janssen Research & Development in Raritan, New Jersey, and colleagues examined the incidence of serious adverse events of DKA among canagliflozin-treated patients with type 2 diabetes. Data